Skip to main content
. 2021 May 3;10(5):524. doi: 10.3390/antibiotics10050524

Figure 11.

Figure 11

Cell viability and glucose uptake efficiency of nanocomposite treated IR-HepG2 cells. AO/EB staining of various samples treated IR-HepG2 cells—(A); glucose uptake efficiency of nanocomposites—(B). (** p < 0.01), (* p < 0.05).